These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
45. Pharmacodynamic models for discrete data. Paule I; Girard P; Freyer G; Tod M Clin Pharmacokinet; 2012 Dec; 51(12):767-86. PubMed ID: 23179578 [TBL] [Abstract][Full Text] [Related]
46. Analgesic efficacy of celecoxib in postoperative oral surgery pain: a single-dose, two-center, randomized, double-blind, active- and placebo-controlled study. Cheung R; Krishnaswami S; Kowalski K Clin Ther; 2007; 29 Suppl():2498-510. PubMed ID: 18164917 [TBL] [Abstract][Full Text] [Related]
47. Utility and sensitivity of the sore throat pain model: results of a randomized controlled trial on the COX-2 selective inhibitor valdecoxib. Schachtel BP; Pan S; Kohles JD; Sanner KM; Schachtel EP; Bey M J Clin Pharmacol; 2007 Jul; 47(7):860-70. PubMed ID: 17525166 [TBL] [Abstract][Full Text] [Related]
48. Preclinical pharmacology profile of CS-706, a novel cyclooxygenase-2 selective inhibitor, with potent antinociceptive and anti-inflammatory effects. Ushiyama S; Yamada T; Murakami Y; Kumakura S; Inoue S; Suzuki K; Nakao A; Kawara A; Kimura T Eur J Pharmacol; 2008 Jan; 578(1):76-86. PubMed ID: 17920584 [TBL] [Abstract][Full Text] [Related]
49. Tailor-made drug treatment for children: creation of an infrastructure for data-sharing and population PK-PD modeling. Ince I; de Wildt SN; Tibboel D; Danhof M; Knibbe CA Drug Discov Today; 2009 Mar; 14(5-6):316-20. PubMed ID: 19059496 [TBL] [Abstract][Full Text] [Related]
50. Modeling and simulation to support dose selection and clinical development of SC-75416, a selective COX-2 inhibitor for the treatment of acute and chronic pain. Kowalski KG; Olson S; Remmers AE; Hutmacher MM Clin Pharmacol Ther; 2008 Jun; 83(6):857-66. PubMed ID: 17882158 [TBL] [Abstract][Full Text] [Related]